Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE STATES AND CONDITIONS

No-Receipt date 2024-02096 - 04/06/2024
No-Filing date 20240401295 - 04/06/2024
No-Granting date 3115564 - 10/06/2024
No-EPO application date 19842049.9 - 22/07/2019
No-EPO granting date 3823617 - 06/03/2024
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 6/2024 - 16/07/2024
Expiration date 23/07/2039
Kind of title Validation of European Patent
Legal status VALID
Priorities US201862701726 P21/07/2018/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 31/47
A61P 35/00
C07C 309/19
C07C 309/29
C07C 309/35
C07D 405/04

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1616086 LINNAEUS THERAPEUTICS, INC. 30 WASHINGTON AVE SUITE FHADDONFIELD NJ 08033 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
4213064 NATALE, CHRISTOPHER
4213065 MOONEY, PATRICK
4213066 GARYANTES, TINA
4213067 LUKE, WAYNE

Representatives
CodeFirstnameSurnameAddressTownZip
3614AIKATERINISIOTOU "KATERINA SIOTOU KAI SYNERGATES DIKIGORIKI ETAIREIA"PATISION (28IS OKTOVRIOU) 122ATHINA (ATTIKIS)11257

Contact
CodeFirstnameSurnameAddressTownZipCountry
4766AIKATERINISIOTOUPATISION (28IS OKTOVRIOU) 122ATHINA (ATTIKIS)11257 GREECE

Owners History

Title Instruments

Payments history 7 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015